Fecal microbiota transplant improved or alleviated symptoms in 70% of patients with refractory irritable bowel syndrome, a small retrospective study has determined.
A single transfusion of fresh...
What the internist has learnt from REPOSI?
In the third millennium, internists and geriatricians must acquire a leading role, together with primary care physi- cians, in order to make health care systems fit for the management of an aging population. Are we ready for this formidable task?
The... more
Vedolizumab was not superior to placebo for inducing remission at 6 weeks in patients with Crohn’s disease who failed to respond to anti–tumor necrosis factor therapy, according to findings from the...
A gluten-free diet benefited asymptomatic patients with serologic markers for celiac disease in a prospective randomized study.
The findings support active screening for celiac disease in patients...
Maintenance treatment with infliximab beyond 1 year after ileocolonic resection for Crohn’s disease was associated with reduced recurrence in a prospective, open-label long-term follow-up...
Patients undergoing cardiac surgery who took colchicine had significantly less postpericardiotomy syndrome than did those on placebo, but this protective effect did not extend to postoperative atrial...
Finding healthy stool donors for fecal transplant may be a tough prospect.
That’s what Australian researchers have discovered in the course of the <link...
Fecal microbiota transplantation successfully treated severe and/or complicated Clostridium difficile infection in a retrospective, multicenter, long-term follow-up study of 17 patients in...
Approximately 75% of cancer patients with major depression are not receiving treatment for their depression, according to an analysis of data from more than 21,000 patients.
However, a novel...
Patients in Norway who underwent removal of low-risk colorectal adenomas but did not get further colonoscopic surveillance showed a 25% lower risk of death from colorectal cancer 8 years later,...